Estrogen And Alzheimers Disease

Estrogen's role in Alzheimer's disease has been a subject of significant research. Estrogen, a hormone primarily associated with female reproductive health, also influences brain function, including memory and cognition. Studies suggest that estrogen may have neuroprotective effects, potentially reducing the risk of Alzheimer's disease in women. However, the relationship is complex, as estrogen's benefits seem to vary depending on age, timing of hormone exposure (such as menopausal status), and individual genetic factors. Some research indicates that estrogen therapy after menopause might help maintain cognitive function and reduce the risk of dementia. Yet, the use of estrogen therapy remains controversial due to associated risks, such as cardiovascular complications and certain types of cancer. Further research is crucial to clarify estrogen's precise role in Alzheimer's disease and to develop safer therapeutic strategies.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China
Tags

Submit your abstract Today

Whatsapp